Elon Musk's Neuralink has received approval to begin a human brain implant trial for paralysis patients

Elon Musk's brain-chip business Neuralink said on Tuesday that an independent review board has approved the start of recruiting for the first human trial of its brain implant for paralysis sufferers.

Those suffering paralysis due to cervical spinal cord damage or amyotrophic lateral sclerosis may be eligible for the research, which will take around six years to complete.

According to Neuralink, the project will employ a robot to surgically implant a brain-computer interface (BCI) implant in a part of the brain that regulates the intention to move, with the initial objective of allowing patients to control a computer cursor or keyboard using just their thoughts.

According to current and former workers, the business, which had planned to get clearance to implant its device in 10 patients, was negotiating a smaller number of patients with the US Food and Drug Administration (FDA) when the agency voiced safety concerns. It is unknown how many people the FDA finally authorized.

Musk has lofty goals for Neuralink, claiming that it would enable rapid surgical insertions of its chip devices to cure illnesses like as obesity, autism, depression, and schizophrenia.

In May, the business announced that it had won FDA approval for its first-in-human clinical study, despite the fact that it was already under government inspection for its animal testing practices.

Even if the BCI gadget is found to be safe for human use, it might take the firm more than a decade to obtain commercial usage certification, according to experts.

Tags: #elonmusk #neuralink #humanbrain #humanbrainimplant #paralysis #paralysispatients #technews #techtainmentora #googlenews #googlediscover #elonmuskneuralink